Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robyn M. Scherber, MD, MPH
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
116 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Bayamón, Puerto Rico
- Facility name not stated
Ponce, Puerto Rico
- Facility name not stated
Huntsville, Alabama, United States
- Facility name not stated
Tempe, Arizona, United States
- Facility name not stated
Tucson, Arizona, United States
- Facility name not stated
Little Rock, Arkansas, United States
- Facility name not stated
Berkeley, California, United States
- Facility name not stated
Highland, California, United States
- Facility name not stated
Long Beach, California, United States
- Facility name not stated
Oceanside, California, United States
- Facility name not stated
Palo Alto, California, United States
- Facility name not stated
Santa Rosa, California, United States
- Facility name not stated
Aurora, Colorado, United States
- Facility name not stated
Colorado Springs, Colorado, United States
- Facility name not stated
Fort Collins, Colorado, United States
- Facility name not stated
Middletown, Connecticut, United States
- Facility name not stated
Washington D.C., District of Columbia, United States
- Facility name not stated
Aventura, Florida, United States
- Facility name not stated
Boynton Beach, Florida, United States
- Facility name not stated
Fort Lauderdale, Florida, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Pembroke Pines, Florida, United States
- Facility name not stated
Tampa, Florida, United States
- Facility name not stated
Winter Haven, Florida, United States
- Facility name not stated
Columbus, Georgia, United States
- Facility name not stated
Marietta, Georgia, United States
- Facility name not stated
Thomasville, Georgia, United States
- Facility name not stated
Boise, Idaho, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Elk Grove Village, Illinois, United States
- Facility name not stated
Harvey, Illinois, United States
- Facility name not stated
Maywood, Illinois, United States
- Facility name not stated
Normal, Illinois, United States
- Facility name not stated
River Forest, Illinois, United States
- Facility name not stated
Skokie, Illinois, United States
- Facility name not stated
Anderson, Indiana, United States
- Facility name not stated
Avon, Indiana, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
Terre Haute, Indiana, United States
- Facility name not stated
Ames, Iowa, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2016
- Primary completion
- 29 Mar 2022
- Completion
- 29 Mar 2022
- Last update posted
- 13 May 2022
- Registered enrollment
- 1,469
- Registry id
- NCT02953704
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.